Zimmer Biomet
1,011 hedge funds and large institutions have $28.4B invested in Zimmer Biomet in 2020 Q4 according to their latest regulatory filings, with 160 funds opening new positions, 284 increasing their positions, 363 reducing their positions, and 66 closing their positions.
142% more first-time investments, than exits
New positions opened: 160 | Existing positions closed: 66
125% more call options, than puts
Call options by funds: $66.8M | Put options by funds: $29.7M
14% more capital invested
Capital invested by funds: $24.9B → $28.4B (+$3.54B)
9% more funds holding
Funds holding: 930 → 1,011 (+81)
0.37% more ownership
Funds ownership: 91.23% → 91.6% (+0.37%)
7% less funds holding in top 10
Funds holding in top 10: 14 → 13 (-1)
22% less repeat investments, than reductions
Existing positions increased: 284 | Existing positions reduced: 363
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$544M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$317M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$123M |
| 4 |
CVA
Ceredex Value Advisors
Orlando,
Florida
|
+$59.1M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$44.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$174M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$148M |
| 3 |
JP Morgan Chase
New York
|
-$132M |
| 4 |
HM
HealthCor Management
New York
|
-$110M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$108M |
ZBH Hedge Fund Activity: Q4 2020 in Review
1,011 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q4 2020, worth a combined $28.4B — up 14% from $24.9B a quarter earlier.
Buyers outnumbered sellers: 160 funds opened new ZBH positions and 66 closed out — a net gain of 94 holders — while 284 added to existing stakes and 363 trimmed.
The largest buyer was BlackRock, adding an estimated $544M. The largest seller was Invesco, cutting an estimated $174M.
- 1,011 institutional investors held Zimmer Biomet (ZBH) as of Q4 2020, up from 930 in Q3 2020.
- Funds reported $28.4B of Zimmer Biomet stock for Q4 2020, up 14% quarter-over-quarter.
- 160 funds opened new Zimmer Biomet positions in Q4 2020 and 66 closed out, a net change of +94 holders.
- The largest Zimmer Biomet buyer in Q4 2020 was BlackRock, an estimated $544M added.
- The largest Zimmer Biomet seller in Q4 2020 was Invesco, an estimated $174M sold.
Based on aggregated 13F filings for Q4 2020.